Chapter 21 : Evasion of Innate Host Antiviral Defenses by Picornaviruses

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in

Evasion of Innate Host Antiviral Defenses by Picornaviruses, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815561/9781555814366_Chap21-1.gif /docserver/preview/fulltext/10.1128/9781555815561/9781555814366_Chap21-2.gif


The family includes a number of medically important viruses, such as poliovirus (PV) and hepatitis A virus (HAV); viruses of significance to veterinary medicine, such as foot-and-mouth disease virus (FMDV); and encephalomyocarditis virus (EMCV), a murine virus with broad capabilities to infect other animal species that has been used widely in studies of the interaction of viruses with the interferon (IFN) system. The remarkable diversity that is evident in these adaptive strategies across the various picornaviral genera suggests that they are relatively recent additions in the evolution of the picornaviruses. In the case of PV and most other picornaviruses, the 3A association appears to be primarily with membranes derived from the ER. The studies described above reveal that the picornaviruses have evolved multiple strategies for evading innate antiviral host defenses, but they are in no way complete for even one member of this large virus family. The diversity of specialized mechanisms of evasion found in only certain groups of viruses, is likely to reflect, at least in part, differences in the tissue tropisms of various picornaviruses, as well as the redundant nature of innate antiviral defenses. Expression of a cleavage-resistant G3PB mutant preserved the ability of the cell to assemble stress granules late in the infection cycle, and also reduced the yields of PV. Although roles for stress granule formation and autophagy in innate cellular defenses against picornaviruses remain speculative, these are likely to be productive lines of future investigation.

Citation: Lemon S. 2009. Evasion of Innate Host Antiviral Defenses by Picornaviruses, p 335-351. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch21
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1
Figure 1

Basic replication scheme of picornaviruses: (a) virus uptake occurs through a process of receptor-mediated endocytosis leading to release of the positive-strand RNA genome into the cytoplasm; (b) cap-independent translation of the genomic RNA leads to expression of a large polyprotein; (c) the polyprotein is processed into structural (shaded) and nonstructural (not shaded) proteins by a well-coordinated series of viral protease-mediated cleavages; (d) nonstructural proteins assemble as replicase complexes at the 3′ end of the genomic RNA within double-membrane vesicles derived from a reordering of intracellular membranes, and initiate the synthesis of complementary negative-strand RNA, leading to production of dsRNA; (e) multiple copies of positive-strand genomic RNA are transcribed from the negative-strand intermediates; (f) newly synthesized positive-strand progeny assemble with structural proteins to form new viral particles, which are released from the cell through both lytic and nonlytic pathways. Replication occurs within the cytoplasm and involves a number of cellular proteins, some of which are normally localized in the nucleus.

Citation: Lemon S. 2009. Evasion of Innate Host Antiviral Defenses by Picornaviruses, p 335-351. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch21
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Polyprotein organization of viruses within the five major picornaviral genera, showing the general order of the individual mature proteins (L-VP4-VP2-VP3-VP1-2A-2B-2C-3A-3B-3C-3D) that are produced by proteolytic processing directed by virally encoded proteases (shaded proteins). All members of the family express a cysteine protease (3C) that is responsible for most polyprotein processing events. Some genera express additional proteases (2A in enteroviruses and rhinoviruses and L in the aphthoviruses) that act in on the polyprotein and also target cellular proteins that are critical for cellular transcription and/or translation. Precursor proteins may also have specific proteolytic activities, such as 3ABC in the hepatoviruses, which targets MAVS/IPS-1 for cleavage. The amino acid residues flanking each cleavage site are shown for each of the polyproteins and are generally conserved within each picornaviral genus. 3D is the conserved RNA-dependent RNA polymerase. (Modified from reference .)

Citation: Lemon S. 2009. Evasion of Innate Host Antiviral Defenses by Picornaviruses, p 335-351. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch21
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Agol, V. I.,, A. V. Paul, and, E. Wimmer. 1999. Paradoxes of the replication of picornaviral genomes. Virus Res. 62:129147.
2. Al-Salleeh, F., and, T. M. Petro. 2007. TLR3 and TLR7 are involved in expression of IL-23 subunits while TLR3 but not TLR7 is involved in expression of IFN-beta by Theiler’s virus-infected RAW264.7 cells. Microbes Infect. 9:13841392.
3. Barral, P. M.,, J. M. Morrison,, J. Drahos,, P. Gupta,, D. Sarkar,, P. B. Fisher, and, V. R. Racaniello. 2007. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 81:36773684.
4. Belov, G. A.,, P. V. Lidsky,, O. V. Mikitas,, D. Egger,, K. A. Lukyanov,, K. Bienz, and, V. I. Agol. 2004. Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores. J. Virol. 78:1016610177.
5. Belov, G. A.,, L. I. Romanova,, E. A. Tolskaya,, M. S. Kolesnikova,, Y. A. Lazebnik, and, V. I. Agol. 2003. The major apoptotic pathway activated and suppressed by poliovirus. J. Virol. 77:4556.
6. Bienz, K.,, D. Egger,, T. Pfister, and, M. Troxler. 1992. Structural and functional characterization of the poliovirus replication complex. J. Virol. 66:27402747.
7. Black, T. L.,, G. N. Barber, and, M. G. Katze. 1993. Degradation of the interferon-induced 68,000-Mr protein kinase by poliovirus requires RNA. J. Virol. 67:791800.
8. Black, T. L.,, B. Safer,, A. Hovanessian, and, M. G. Katze. 1989. The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. J. Virol. 63:22442251.
9. Brack, K.,, I. Berk,, T. Magulski,, J. Lederer,, A. Dotzauer, and, A. Vallbracht. 2002. Hepatitis A virus inhibits cellular antiviral defense mechanisms induced by double-stranded RNA. J. Virol. 76:1192011930.
10. Brown, C. C.,, M. E. Piccone,, P. W. Mason,, T. S. C. McKenna, and, M. J. Grubman. 1996. Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J. Virol. 70:56385641.
11. Buenz, E. J., and, C. L. Howe. 2006. Picornaviruses and cell death. Trends Microbiol. 14:2836.
12. Cayley, P. J.,, M. Knight, and, I. M. Kerr. 1982. Virus-mediated inhibition of the ppp(A2′p)nA system and its prevention by interferon. Biochem. Biophys. Res. Commun. 104:376382.
13. Chen, Y.,, E. Hamati,, P. K. Lee,, W. M. Lee,, S. Wachi,, D. Schnurr,, S. Yagi,, G. Dolganov,, H. Boushey,, P. Avila, and, R. Wu. 2006. Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways. Am. J. Respir. Cell Mol. Biol. 34:192203.
14. Chinsangaram, J.,, M. Koster, and, M. J. Grubman. 2001. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol. 75:54985503.
15. Cho, M. W.,, N. Teterina,, D. Egger,, K. Bienz, and, E. Ehrenfeld. 1994. Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology 202:129145.
16. Choe, S. S.,, D. A. Dodd, and, K. Kirkegaard. 2005. Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology 337:1829.
17. Deitz, S. B.,, D. A. Dodd,, S. Cooper,, P. Parham, and, K. Kirkegaard. 2000. MHC I-dependent antigen presentation is inhibited by poliovirus 3A. Proc. Natl. Acad. Sci. USA 97:1379013795.
18. Delhaye, S.,, V. van Pesch, and, T. Michiels. 2004. The leader protein of Theiler’s virus interferes with nucleocytoplasmic trafficking of cellular proteins. J. Virol. 78:43574362.
19. de Los Santos, T.,, F. Diaz-San Segundo, and, M. J. Grubman. 2007. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J. Virol. 81:1280312815.
20. de Los Santos, T.,, S. de Avila Botton,, R. Weiblen, and, M. J. Grubman. 2006. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 80:19061914.
21. Devaney, M. A.,, V. N. Vakharia,, R. E. Lloyd,, E. Ehrenfeld, and, M. J. Grubman. 1988. Leader protein of foot-and-mouth disease virus is required for cleavage of the p200 component of the cap-binding protein complex. J. Virol. 62:44074409.
22. Dodd, D. A.,, T. H. Giddings, Jr., and, K. Kirkegaard. 2001. Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection. J. Virol. 75:81588165.
23. Doerdens, J. R.,, T. H. Giddings, Jr., and, K. Kirkegaard. 1997. Inhibition of ER-to-Golgi traffic by poliovirus 3A: genetic and ultrastructural analysis. J. Virol. 71:90549064.
24. Duke, G. M.,, J. E. Osorio, and, A. C. Palmenberg. 1990. Attenuation of Mengo virus through genetic engineering of the 5′ noncoding poly(C) tract. Nature 343:474476.
25. Enninga, J.,, D. E. Levy,, G. Blobel, and, B. M. Fontoura. 2002. Role of nucleoporin induction in releasing an mRNA nuclear export block. Science 295:15231525.
26. Faria, P. A.,, P. Chakraborty,, A. Levay,, G. N. Barber,, H. J. Ezelle,, J. Enninga,, C. Arana,, J. van Deursen, and, B. M. Fontoura. 2005. VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol. Cell 17:93102.
27. Fensterl, V.,, D. Grotheer,, I. Berk,, S. Schlemminger,, A. Vallbracht, and, A. Dotzauer. 2005. Hepatitis A virus suppresses RIG-I-mediated IRF3 activation to block induction of beta interferon. J. Virol. 79:1096810977.
28. Fitzgerald, K. A.,, S. M. McWhirter,, K. L. Faia,, D. C. Rowe,, E. Latz,, D. T. Golenbock,, A. J. Coyle,, S. M. Liao, and, T. Maniatis. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491496.
29. Foy, E.,, K. Li,, C. Wang,, R. Sumter,, M. Ikeda,, S. M. Lemon, and, M. Gale, Jr. 2003. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine pro-tease. Science 300:11451148.
30. Gale, M., Jr., and, E. M. Foy. 2005. Evasion of intracellular host defence by hepatitis C virus. Nature 436:939945.
31. Gale, M., Jr., and, M. G. Katze. 1998. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78:2946.
32. Gitlin, L.,, W. Barchet,, S. Gilfillan,, M. Cella,, B. Beutler,, R. A. Flavell,, M. S. Diamond, and, M. Colonna. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA 103:84598464.
33. Grandvaux, N.,, M. J. Servant,, B. tenOever,, G. C. Sen,, S. Balachandran,, G. N. Barber,, R. Lin, and, J. Hiscott. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76:55325539.
34. Gustin, K. E., and, P. Sarnow. 2002. Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. J. Virol. 76:87878796.
35. Hahn, H., and, A. C. Palmenberg. 1995. Encephalomyocarditis viruses with short poly(C) tracts are more virulent than their mengovirus counterparts. J. Virol. 69:26972699.
36. Han, J. Q., and, D. J. Barton. 2002. Activation and evasion of the antiviral 2′-5′ oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA. RNA 8:512525.
37. Han, J. Q.,, H. L. Townsend,, B. K. Jha,, J. M. Paranjape,, R. H. Silverman, and, D. J. Barton. 2007. A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L. J. Virol. 81:55615572.
38. Hiscott, J. 2007. Triggering the innate antiviral response through IRF3 activation. J. Biol. Chem. 282:1532515329.
39. Hornung, V.,, J. Ellegast,, S. Kim,, K. Brzózka,, A. Jung,, H. Kato,, H. Poeck,, S. Akira,, K. K. Conzelmann,, M. Schlee,, S. Endres, and, G. Hartmann. 2006. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314:994997.
40. Iordanov, M. S.,, J. M. Paranjape,, A. Zhou,, J. Wong,, B. R. Williams,, E. F. Meurs,, R. H. Silverman, and, B. E. Magun. 2000. Activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol. Cell. Biol. 20:617627.
41. Iordanov, M. S.,, J. Wong,, J. C. Bell, and, B. E. Magun. 2001. Activation of NF-kappaB by double-stranded RNA (dsRNA) in the absence of protein kinase R and RNase L demonstrates the existence of two separate dsRNA-triggered antiviral programs. Mol. Cell. Biol. 21:6172.
42. Kabelitz, D., and, R. Medzhitov. 2007. Innate immunity— cross-talk with adaptive immunity through pattern recognition receptors and cytokines. Curr. Opin. Immunol. 19:13.
43. Kato, H.,, O. Takeuchi,, S. Sato,, M. Yoneyama,, M. Yamamoto,, K. Matsui,, S. Uematsu,, A. Jung,, T. Kawai,, K. J. Ishii,, O. Yamaguchi,, K. Otsu,, T. Tsujimura,, C. S. Koh,, C. Reis e Sousa,, Y. Matsuura,, T. Fujita, and, S. Akira. 2006. Differential roles of MDA-5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101105.
44. Korpi-Steiner, N. L.,, M. E. Bates,, W. M. Lee,, D. J. Hall, and, P. J. Bertics. 2006. Human rhinovirus induces robust IP-10 release by monocytic cells, which is independent of viral replication but linked to type I interferon receptor ligation and Stat1 activation. J. Leukoc. Biol. 80:13641374.
45. Laza-Stanca, V.,, L. A. Stanciu,, S. D. Message,, M. R. Edwards,, J. E. Gern, and, S. L. Johnston. 2006. Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production. J. Virol. 80:82488258.
46. Lee, H. K.,, J. M. Lund,, B. Ramanathan,, N. Mizushima, and, A. Iwasaki. 2007. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315:13981401.
47. Lemon, S. M.,, L. N. Binn,, R. Marchwicki,, P. C. Murphy,, L.-H. Ping,, R. W. Jansen,, L. V. S. Asher,, J. T. Stapleton,, D. G. Taylor, and, J. W. LeDuc. 1990. In vivo replication and reversion to wild-type of a neutralization-resistant variant of hepatitis A virus. J. Infect. Dis. 161:713.
48. Levine, B., and, V. Deretic. 2007. Unveiling the roles of autophagy in innate and adaptive immunity. Nat. Rev. Immunol. 7:767777.
49. Li, K.,, E. Foy,, J. C. Ferreon,, M. Nakamura,, A. C. M. Ferreon,, M. Ikeda,, S. C. Ray,, M. Gale, Jr., and, S. M. Lemon. 2005. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the TLR3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA 102:29922997.
50. Li, X. D.,, L. Sun,, R. B. Seth,, G. Pineda, and, Z. J. Chen. 2005. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. USA 102:1771717722.
51. Li, X. L.,, J. A. Blackford, and, B. A. Hassel. 1998. RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection. J. Virol. 72:27522759.
52. Lidsky, P. V.,, S. Hato,, M. V. Bardina,, A. G. Aminev,, A. C. Palmenberg,, E. V. Sheval,, V. Y. Polyakov,, F. J. van Kuppeveld, and, V. I. Agol. 2006. Nucleocytoplasmic traffic disorder induced by cardioviruses. J. Virol. 80:27052717.
53. Lin, R.,, C. Heylbroeck,, P. M. Pitha, and, J. Hiscott. 1998. Virus-dependent phosphorylation of the IRF3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18:29862996.
54. Lloyd, R. E. 2006. Translational control by viral proteinases. Virus Res. 119:7688.
55. Loo, Y. M.,, D. M. Owen,, K. Li,, A. L. Erickson,, C. L. Johnson,, P. Fish,, D. S. Carney,, T. Wang,, H. Ishida,, M. Yoneyama,, T. Fujita,, T. Saito,, W. M. Lee,, C. H. Hagedorn,, D. T. Lau,, S. A. Weinman,, S. M. Lemon, and, M. Gale, Jr. 2006. Viral and therpeutic control of interferon beta promoter stimulator 1 during hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 103:60016006.
56. Malathi, K.,, B. Dong,, M. Gale, Jr., and, R. H. Silverman. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448:816819.
57. Malirat, V.,, P. A. De Mello,, B. Tiraboschi,, E. Beck,, I. Gomes, and, I. E. Bergmann. 1994. Genetic variation of foot-and-mouth disease virus during persistent infection in cattle. Virus Res. 34:3148.
58. Martin, A., and, S. M. Lemon. 2002. The molecular biology of hepatitis A virus, p. 23–50. In J.-H. Ou (ed.), Hepatitis Viruses. Kluwer Academic Publishers, Norwell, MA.
59. Martinand, C.,, T. Salehzada,, M. Silhol,, B. Lebleu, and, C. Bisbal. 1998. RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2–5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells. Eur. J. Biochem. 254:248255.
60. Martinand, C.,, T. Salehzada,, M. Silhol,, B. Lebleu, and, C. Bisbal. 1998. The RNase L inhibitor (RLI) is induced by double-stranded RNA. J. Interferon Cytokine Res. 18:10311038.
61. Mazroui, R.,, R. Sukarieh,, M. E. Bordeleau,, R. J. Kaufman,, P. Northcote,, J. Tanaka,, I. Gallouzi, and, J. Pelletier. 2006. Inhibition of ribosome recruitment induces stress granule formation independently of eukaryotic initiation factor 2alpha phosphorylation. Mol. Biol. Cell 17:42124219.
62. Meylan, E.,, J. Curran,, K. Hofmann,, D. Moradpour,, M. Binder,, R. Bartenschlager, and, J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:11671172.
63. Moran, J. M.,, M. A. Moxley,, R. M. Buller, and, J. A. Corbett. 2005. Encephalomyocarditis virus induces PKR-independent mitogen-activated protein kinase activation in macrophages. J. Virol. 79:1022610236.
64. Neznanov, N.,, K. M. Chumakov,, L. Neznanova,, A. Almasan,, A. K. Banerjee, and, A. V. Gudkov. 2005. Proteolytic cleavage of the p65-RelA subunit of NFkappaB during poliovirus infection. J. Biol. Chem. 280:2415324158.
65. Neznanov, N.,, A. Kondratova,, K. M. Chumakov,, B. Angres,, B. Zhumabayeva,, V. I. Agol, and, A. V. Gudkov. 2001. Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surface. J. Virol. 75:1040910420.
66. Park, N.,, P. Katikaneni,, T. Skern, and, K. E. Gustin. 2008. Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J. Virol. 82:16471655.
67. Paul, A. V.,, J. H. Van Boom,, D. Filippov, and, E. Wimmer. 1998. Protein-primed RNA synthesis by purified poliovirus RNA polymerase. Nature 393:280284.
68. Paul, S., and, T. Michiels. 2006. Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness. J. Gen. Virol. 87:12371246.
69. Pelletier, J., and, N. Sonenberg. 1988. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334:320325.
70. Pichlmair, A.,, O. Schulz,, C. P. Tan,, T. I. Naslund,, P. Liljestrom,, F. Weber,, M. Reiser, and, C. Reis e Sousa. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′ phosphates. Science 314:9991001.
71. Porter, F. W.,, Y. A. Bochkov,, A. J. Albee,, C. Wiese, and, A. C. Palmenberg. 2006. A picornavirus protein interacts with Ran-GTPase and disrupts nucleocytoplasmic transport. Proc. Natl. Acad. Sci. USA 103:1241712422.
72. Provost, P. J.,, P. A. Giesa,, W. J. McAleer, and, M. R. Hilleman. 1981. Isolation of hepatitis A virus in vitro in cell culture directly from human specimens. Proc. Soc. Exper. Biol. Med. 167:201206.
73. Ransone, L. J., and, A. Dasgupta. 1988. A heat-sensitive inhibitor in poliovirus-infected cells which selectively blocks phosphorylation of the alpha subunit of eucaryotic initiation factor 2 by the double-stranded RNA-activated protein kinase. J. Virol. 62:35513557.
74. Rieder, E.,, T. Bunch,, F. Brown, and, P. W. Mason. 1993. Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J. Virol. 67:51395145.
75. Romanova, L. I.,, G. A. Belov,, P. V. Lidsky,, E. A. Tolskaya,, M. S. Kolesnikova,, A. G. Evstafieva,, A. B. Vartapetian,, D. Egger,, K. Bienz, and, V. I. Agol. 2005. Variability in apoptotic response to poliovirus infection. Virology 331:292306.
76. Santoro, M. G.,, A. Rossi, and, C. Amici. 2003. NFkappaB and virus infection: who controls whom. EMBO J. 22:25522560.
77. Scheuner, D.,, M. Gromeier,, M. V. Davies,, A. J. Dorner,, B. Song,, R. V. Patel,, E. J. Wimmer,, R. E. McLendon, and, R. J. Kaufman. 2003. The double-stranded RNA-activated protein kinase mediates viral-induced encephalitis. Virology 317:263274.
78. Schulman, A. N.,, J. L. Dienstag,, D. R. Jackson,, J. H. Hoofnagle,, R. J. Gerety,, R. H. Purcell, and, L. F. Barker. 1976. Hepatitis A antigen particles in liver, bile, and stool of chimpanzees. J. Infect. Dis. 134:8084.
79. Silverman, R. H. 2007. Viral encounters with 2′,5′-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 81:1272012729.
80. Silverman, R. H.,, P. J. Cayley,, M. Knight,, C. S. Gilbert, and, I. M. Kerr. 1982. Control of the ppp(a2′ p)nA system in HeLa cells. Effects of interferon and virus infection. Eur. J. Biochem. 124:131138.
81. So, E. Y.,, M. H. Kang, and, B. S. Kim. 2006. Induction of chemokine and cytokine genes in astrocytes following infection with Theiler’s murine encephalomyelitis virus is mediated by the Toll-like receptor 3. Glia 53:858867.
82. Stanway, G.,, F. Brown,, P. Christian,, T. Hovi,, T. Hyypiä,, A. M. Q. King,, N. J. Knowles,, S. M. Lemon,, P. D. Minor,, M. A. Pallansch,, A. Palmenberg, and, T. Skern. 2005. Family Picornaviridae, p. 757–778. In C. M. Fauquet,, M. A. Mayo,, J. Maniloff,, U. Desselberger, and, L. A. Ball (ed.), Virus Taxonomy. Eighth Report of the International Committee on Taxonomy of Viruses. Elsevier/Academic Press, London, U.K.
83. Strong, R., and, G. J. Belsham. 2004. Sequential modification of translation initiation factor eIF4GI by two different foot-and-mouth disease virus proteases within infected baby hamster kidney cells: identification of the 3Cpro cleavage site. J. Gen. Virol. 85:29532962.
84. Sumpter, R., Jr.,, M. Y. Loo,, E. Foy,, K. Li,, M. Yoneyama,, T. Fujita,, S. M. Lemon, and, M. J. Gale, Jr. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:26892699.
85. Takeuchi, O., and, S. Akira. 2007. Recognition of viruses by innate immunity. Immunol. Rev. 220:214224.
86. Takeuchi, O., and, S. Akira. 2007. Signaling pathways activated by microorganisms. Curr. Opin. Cell Biol. 19:185191.
87. Taylor, M. P., and, K. Kirkegaard. 2007. Modification of cellular autophagy protein LC3 by poliovirus. J. Virol. 81:1254312553.
88. Todd, S., and, B. L. Semler. 1996. Structure-infectivity analysis of the human rhinovirus genomic RNA 3′ non-coding region. Nucleic Acids Res. 24:21332142.
89. Triantafilou, K.,, G. Orthopoulos,, E. Vakakis,, M. A. Ahmed,, D. T. Golenbock,, P. M. Lepper, and, M. Triantafilou. 2005. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell. Microbiol. 7:11171126.
90. Triantafilou, K.,, E. Vakakis,, G. Orthopoulos,, M. A. Ahmed,, C. Schumann,, P. M. Lepper, and, M. Triantafilou. 2005. TLR8 and TLR7 are involved in the host’s immune response to human parechovirus 1. Eur. J. Immunol. 35:24162423.
91. Vallbracht, A.,, L. Hofmann,, K. G. Wurster, and, B. Flehmig. 1984. Persistent infection of human fibroblasts by hepatitis A virus. J. Gen. Virol. 65:609615.
92. van Pesch, V.,, O. van Eyll, and, T. Michiels. 2001. The leader protein of Theiler’s virus inhibits immediate-early alpha/beta interferon production. J. Virol. 75:78117817.
93. Wathelet, M. G.,, C. H. Lin,, B. S. Parekh,, L. V. Ronco,, P. M. Howley, and, T. Maniatis. 1998. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1:507518.
94. White, J. P.,, A. M. Cardenas,, W. E. Marissen, and, R. E. Lloyd. 2007. Inhibition of cytoplasmic mRNA stress granule formation by a viral proteinase. Cell Host Microbe 2:295305.
95. Wimmer, E.,, C. U. T. Hellen, and, X. Cao. 1993. Genetics of poliovirus. Annu. Rev. Genet. 27:353436.
96. Yang, Y.,, Y. Liang,, L. Qu,, Z. Chen,, M. Yi,, K. Li, and, S. M. Lemon. 2007. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl. Acad. Sci. USA 104:72537258.
97. Yang, Y.,, R. Rijnbrand,, K. L. McKnight,, E. Wimmer,, A. Paul,, A. Martin, and, S. M. Lemon. 2002. Sequence requirements for viral RNA replication and VPg uridylylation directed by the internal cis-acting replication element (cre) of human rhinovirus type 14. J. Virol. 76:74857494.
98. Yang, Y. L.,, L. F. Reis,, J. Pavlovic,, A. Aguzzi,, R. Schafer,, A. Kumar,, B. R. Williams,, M. Aguet, and, C. Weissmann. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14:60956106.
99. Yeung, M. C.,, D. L. Chang,, R. E. Camantigue, and, A. S. Lau. 1999. Inhibitory role of the host apoptogenic gene PKR in the establishment of persistent infection by encephalomyocarditis virus in U937 cells. Proc. Natl. Acad. Sci. USA 96:1186011865.


Generic image for table
Table 1

Abbreviated list of important members of the family

Citation: Lemon S. 2009. Evasion of Innate Host Antiviral Defenses by Picornaviruses, p 335-351. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch21
Generic image for table
Table 2

Strategies evolved by members of the P for evading innate host antiviral defenses

Citation: Lemon S. 2009. Evasion of Innate Host Antiviral Defenses by Picornaviruses, p 335-351. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch21

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error